(Louis) Guinea Dog
by American Printing House for the Blind
Last verified May 24, 2026 · classified May 14, 2026
What it is
Summary
AI-generated from vendor-published content · May 14, 2026
This is a large print edition of 'Guinea Dog,' the children's novel by Patrick Jennings, produced by the American Printing House for the Blind through the Louis accessible media database. It's designed for students with low vision who need enlarged text to read standard classroom or recreational reading material independently. The book is Federal Quota eligible, meaning it can be funded through schools' APH quota accounts — that's the most common funding path for this type of material. At $115, this reflects the specialized production cost of large print educational materials; the same title in standard print costs a fraction of that, so budget planning matters.
Quick Facts Catalog facts · auto-generated
- AT Act lending
- Out of pocket
- School district
What Setup Looks Like
- Out of the box
Open the book and read — no setup required. - With professional help
A teacher of the visually impaired (TVI) or vision specialist should assess the appropriate print size and confirm this large print edition matches the student's needs before ordering through Federal Quota.
Getting it
Try Before You Buy
Devices like this are often available to borrow through your state's AT Act program — typically free or low-cost — so you can try it before buying or pursuing funding.
Where to Get It
Some links may be affiliate links — WhatCanHelp may earn a small commission from purchases at no extra cost to you. More on affiliates →
Wondering how equipment like this gets paid for? See the official funding programs in your state.
Compare & explore
Sources & fine print
Vendor facts (name, price, platforms, vendor link) sourced from American Printing House for the Blind — view on vendor site; last verified May 24, 2026.
Classification & description AI-generated from vendor-published content on May 14, 2026 · confidence: high. Vendor specs may lag; verify before relying on details in a clinical or funding artifact.